Welcome to a Mini-Symposium with a Keynote Presentation by Prof. Tadashi Watabe, Department of Radiology, Osaka University and Osaka University Hospital: "From Astatine to Emerging Targets: Clinical Translation of Theranostics in Osaka".
AGENDA
· Welcome by NERR & OCC
· Introduction of the topic and speaker by Prof. Mona-Elisabeth Rootwelt-Revheim, Oslo University Hospital (OUH) and by Prof. Frederik Giesel , Düsseldorf University Hospital
· Keynote: Prof. Tadashi Watabe, Department of Radiology, Osaka University and Osaka University Hospital: "From Astatine to Emerging Targets: Clinical Translation of Theranostics in Osaka"
Please remember to register your attendance via the link above.
SPEAKER BIO
Prof. Tadashi Watabe, M.D., Ph.D.
Associate Professor, Laboratory for Theranostics, Institute for Radiation Sciences, The University of Osaka
Tadashi Watabe is an Associate Professor at the University of Osaka. He is a board-certified nuclear medicine physician with extensive expertise in theranostics and targeted alpha therapy. He serves as the PI of investigator-initiated clinical trials using 211At and PET research involving [18F]FAPI-74, [18F]FBPA, and [11C]HCA2969. He is also the Executive Congress Chair of the Theranostics World Congress 2027.
Hosts
Hosted by Oslo Cancer Cluster and the National Expert Group for Radiotherapy Research (NERR).
This mini-symposium builds on the May 5th meeting for the Norwegian radiopharma and theranostics ecosystem, and is part of the joint OUS / UiO RLT- and theranostics initiative coordinated by Caroline Stokke and initiated via the Oslo Science City Gravitational Fields Initiative.